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Diarrheal disease is a complex syndrome that remains a leading cause of global childhoodmorbidity andmortality. The diagno-
sis of enteric pathogens in a timely and precise manner is important for making treatment decisions and informing public health
policy, but accurate diagnosis is a major challenge in industrializing countries. Multiplex molecular diagnostic techniques may
represent a significant improvement over classical approaches. We evaluated the Luminex xTAG gastrointestinal pathogen panel
(GPP) assay for the detection of common enteric bacterial and viral pathogens in Vietnam. Microbiological culture and real-time
PCR were used as gold standards. The tests were performed on 479 stool samples collected from people admitted to the hospital
for diarrheal disease throughout Vietnam. Sensitivity and specificity were calculated for the xTAGGPP for the seven principal
diarrheal etiologies. The sensitivity and specificity for the xTAGGPP were>88% for Shigella spp., Campylobacter spp., rotavi-
rus, norovirus genotype 1/2 (GI/GII), and adenovirus compared to those of microbiological culture and/or real-time PCR. How-
ever, the specificity was low (60%) for Salmonella species. Additionally, a number of important pathogens that are not identi-
fied in routine hospital procedures in this setting, such as Cryptosporidium spp. and Clostridium difficile, were detected with the
GPP. The use of the Luminex xTAGGPP for the detection of enteric pathogens in settings, like Vietnam, would dramatically im-
prove the diagnostic accuracy and capacity of hospital laboratories, allowing for timely and appropriate therapy decisions and a
wider understanding of the epidemiology of pathogens associated with severe diarrheal disease in low-resource settings.
Diarrheal disease remains a considerable public health chal-lenge and is responsible for 0.8 million deaths and close to
90,000 disability-adjusted life years annually (1, 2), themajority of
which occur in children5 years of age in industrializing regions
(3). Infectious diarrhea (caused by a pathogenic agent) can be
caused by a number of different viruses, bacteria, and parasites.
Rotavirus remains themost common cause of diarrhea in children
2 years of age (4, 5), although the introduction of rotavirus
vaccines in many countries has led to a fall in incidence in loca-
tionswhere uptake has been significant (6, 7). Bacterial pathogens,
such as Shigella spp., enterotoxigenic Escherichia coli (ETEC),
Campylobacter spp., and Salmonella spp., norovirus, and the par-
asitic pathogensGiardia andCryptosporidium spp. are also known
to be present frequently in the stools of young children with diar-
rhea in resource-poor regions (4, 5, 8). As the etiology of diarrheal
disease is diverse and complex, sensitive and specific diagnostics
are required for prompt and accurate identification and treat-
ment.
The detection of pathogens from stool specimens is challeng-
ing. In settings, such as Ho Chi Minh City (HCMC), Vietnam,
hospital laboratories rarely perform routine microbiological cul-
ture, and if they do, they aim to isolate only a limited range of
bacterial pathogens. Antimicrobial consumption in the commu-
nity further reduces the sensitivity of microbiological culture for
bacterial pathogens (9). Microscopy is used to detect occult white
blood cells, red blood cells, and parasites, such as Entamoeba his-
tolytica, Cryptosporidium spp., and Giardia lamblia; however, mi-
croscopic detection of parasites has poor sensitivity (10) and pres-
ents difficulties due to the requirement of a fresh specimen, the
requirement for an experienced microscopist, and a lack of meth-
odological standardization. In addition, real-time PCR systems
are not used routinely in HCMC (or indeed across Vietnam) due
to the cost, lack of equipment, and a paucity of trained staff. As
such, a number of important pathogens, such as rotavirus, noro-
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virus, pathovars of E. coli, and Clostridium difficile, are not rou-
tinely detected by procedures currently in place. The lack of ap-
propriate diagnostics hinders not only clinical treatment decisions
but also awider understanding of the epidemiology and the public
health implications of severe pediatric diarrheal disease in loca-
tions, like HCMC.
Given the limitations of traditional diagnostics, a multipanel
pathogen identification system that is sensitive, specific, and easy
to operate represents a significant improvement on classical tech-
niques. The Luminex xTAG gastrointestinal pathogen panel assay
(GPP) (Luminex Molecular Diagnostics, Austin, TX, USA) is a
qualitative multiplex test cleared by the U.S. Food and Drug Ad-
ministration (FDA) that is able to identify 19 enteric pathogens in
one reaction in 6 h; however, the assay has a prohibitive cost in
Vietnam of approximately $75 per sample (as of December 2015).
The Luminex platform has been shown to be highly sensitive and
specific for a variety of pathogens in several clinical settings glob-
ally (11–13). In this study, we aimed to evaluate the sensitivity and
specificity of the xTAG GPP platform against those of conven-
tional diagnostic techniques on clinical samples isolated from pa-
tients hospitalized with diarrheal disease in Vietnam.
MATERIALS AND METHODS
Clinical specimens and study procedures. Fecal specimens were col-
lected from 479 patients hospitalized with diarrheal disease from three
different studies across Vietnam during 2009 to 2014. The hospitals in-
cluded in the study were Children’s Hospital 1, Children’s Hospital 2, and
the Hospital of Tropical Diseases in HCMC. Provincial hospitals in Dong
Thap, Dak Lak, KhanhHoa, and Thua ThienHue also participated as part
of the Vietnam Initiative on Zoonotic Infections (VIZIONS) initiative
(14). Patients were admitted at the discretion of the treating clinician and
were excluded from each of the studies if they had suspected or confirmed
intussusception, multiple complications unrelated to diarrheal disease, or
suspected antimicrobial-induced diarrhea. Diarrhea was defined as three
watery or loose stools within 24 h or one episode of bloody and/ormucoid
diarrhea (15). After collection in a sterile container, fresh stool samples
were stored at 4°C at the sites and transported to the central study micro-
biology laboratory within 24 h. The specimens were tested using micro-
biological culture and real-time PCR and then stored in 20% glycerol
solution at80°C.
This study consisted of three components. First, we selected 172 sam-
ples with known etiologies frommicrobiological culture for validation of
the xTAGGPP system. Second, we chose an additional 307 specimens that
were negative by conventional culture methods, microscopy, and real-
time PCR to test with the xTAGGPP to detect pathogens that wemay not
have identified through conventional methodologies. Finally, we used all
of the 479 stool tested samples to evaluate the sensitivity and specificity of
the xTAGGPP for seven pathogens by using culture and real-time PCR as
the gold standards.
Microbial culture and molecular detection of bacterial pathogens.
Stool specimens were cultured on blood agar, MacConkey agar, xylose-
lysine-deoxycholate agar, selenite broth, and Campylobacter media (Ox-
oid, Basingstoke, United Kingdom) to isolate Shigella spp., Salmonella
spp., and Campylobacter species. Apart from Campylobacter plates, which
were incubated microaerophilically at 42°C, all media were incubated at
37°C overnight and then examined for growth, as previously described
(16). Colonies with a morphology indicative of a named pathogen were
subcultured onto nutrient agar for purity, and bacterial identity was con-
firmed by either API 20E (bioMérieux, France) or serotyping, where ap-
plicable. Specific serotypes of Shigella spp. and Salmonella spp. were iden-
tified by slide agglutination with antigen-grouping sera and monovalent
antisera, andCampylobacter jejuniwas differentiated fromCampylobacter
coli by the hippurate hydrolysis test.
All stool specimens were also screened for the presence of Shigella spp.
(target, ipaH), Salmonella spp., and Campylobacter spp. (C. jejuni target,
hipO; C. coli target, glyA) by real-time PCR using the following cycling
conditions: 95°C for 15 min, 40 cycles of 95°C for 5 s, 60°C for 30 s, and
72°C for 30 s, as described previously (17, 18). Salmonella screening was
performed using an in-house assay targeting the invA gene (forward
primer, 5=-TCATCGCACCGTCAAARGA-3=; reverse primer, 5=-CGATT
TGAARGCCGGTATTATT-3=; probe, 5=-FAM-ACGCTTCGCCGTTCR
CGYGC-BHQ1-3= FAM, 6-carboxyfluorescein; BHQ1, black hole
quencher 1), under the following conditions: 95°C for 15min, 45 cycles of
95°C for 5 s, and 60°C for 60 s (19).
Molecular detection of rotavirus, norovirus GI/GII, and adenovi-
rus. For rotavirus and norovirus molecular testing, total RNA was ex-
tracted from fresh stool samples, reverse transcribed into cDNA, and used
as the template to detect viruses by real-time PCR, as previously described
(20). Rotavirus detection was performed by targeting the nonstructural
protein 3 (NSP3). The norovirus primers and probes targeted the open
reading frame 1 (ORF1)-ORF2 junction of norovirus genotype 1/2 (GI/
GII) (21). PCR amplifications for rotavirus and norovirus GI/GII were
performed using RNAMaster hydrolysis probes (Roche Applied Sciences,
United Kingdom) and optimized with 1.4l of activator on a LightCycler
480II (Roche Applied Sciences). Five microliters of RNA was mixed with
a concentration of 20M for each primer and 10Mprobe, and thermal
cycling was initiated at 61°C for 5 min for reverse transcription, 5 min at
95°C for amplification, and then by 45 cycles at 95°C for 5 s and 60°C for
45 s. Adenovirus real-time PCR amplification was performed using prim-
ers AdV-F (TCTTACAAAGTGCGC TTTACGC) and AdV-R (TTAAAG
CTGGGRCCACGATC) and probeAdV-probe (Cy5-GACAACCGGGTK
TTGGACATGGCCAG-BHQ3). Adenovirus DNA was mixed with a
concentration of 20 M for each primer and 10 M probe and LightCycler
480 probes master (Roche Applied Sciences) and subjected a PCR cycle of
95°C for 5 min, followed by 45 cycles of 95°C for 5 s and 60°C for 1 min.
The assay was validated with positive controls using a previously de-
scribed procedure (18).
xTAG gastrointestinal pathogen panel testing. The xTAGGPP assay
is a multiplex assay that simultaneously detects Salmonella spp., Shigella
spp., Campylobacter spp., C. difficile (toxins A and B), enterotoxigenic E.
coli (ETEC) heat labile (LT) and heat stable (ST) enterotoxins, E. coli
O157, Shiga toxin-producing E. coli (STEC) spp.,Vibrio cholerae, Yersinia
enterocolitica, fecal adenovirus 40/41, rotavirus A, norovirus GI/GII, Gi-
ardia spp., E. histolytica, and Cryptosporidium species. For nucleic acid
extraction, 200l of each stool specimenwas automatically extractedwith
10l of xTAGMS2 (internal control) using theMagNAPure-96machine
(Roche), according to the manufacturer’s instructions. The xTAG GPP
assay was performed according to the manufacturer’s recommendations
(Luminex Molecular Diagnostics, Austin, TX, USA).
Statistical analysis. The Luminex data were read by the TDAS soft-
ware and imported and analyzed in Stata version 11 (College Station, TX,
USA). Plots were made in R version 3.1.1 (R Foundation for Statistical
Computing, Vienna, Austria) using the ggplot2 package (22). Sensitivity
and specificity were calculated separately using two gold standards: (i)
microbiological culture and (ii) real-time PCR. As the specificity of the
original Luminex cutoffs for Salmonella spp. was low (60%), we at-
tempted to redefine the cutoffs to improve the sensitivity and specificity
for the Salmonella assay. To evaluate the capacity of probes 1 and 2 in
discriminating between positive and negative Salmonella infection, the
area under the receiver operating characteristic (ROC) curve was com-
puted for univariate logistic regression models (containing either probe 1
or 2 alone as a predictor) and a multivariate logistic regression model
(containing both probes 1 and 2 as predictors). The optimal cut points for
probe 1, probe 2, or for probes 1 and 2 combinedwere estimated using the
Youden index method (in which the sum of sensitivity and specificity of
the logistic models were maximized) (23).
Ethical approval. Stool samples were collected from three studies, all
of whichwere approved by the local ethical committees andOxford Trop-
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ical Research Ethics Committee (OxTREC) (no. 0109, 15-12, and 1045-
13). Written informed consent was required for all patients or from par-
ents/legal guardians if the patient was a child prior to enrollment into all
three studies.
RESULTS
Baseline results. Overall, 479 stool samples were collected from
92 adults (15 years) and 387 children (15 years old) admitted
to the hospital with diarrheal disease in Vietnam between 2009
and 2014. The median age of the adult patients was 50 years (in-
terquartile range [IQR], 33 to 64 years), and 39% (36/92 patients)
were male. In children, themedian age was 16.5 months (IQR, 6.7
to 20months), with 57% (221/387 patients) beingmale. A total of
105 samples (22%) were positive for a bacterial pathogen by mi-
crobiological culture, 268 samples (56%) were positive for a
pathogen by real-time PCR, and 404 samples (84%) were positive
for a pathogen by the xTAGGPP. From the 479 tested samples, the
most commonly identified pathogens through the xTAG GPP
platform were Salmonella (n  210 [44%]), rotavirus (n  121
[25%]), norovirus GII (n 89 [19%]), Shigella (n 91 [19%]),
and Cryptosporidium (n 83 [17%]). Though less common, the
xTAG GPP also detected C. difficile (n 45 [9%]), ETEC (n 40
[8%]),Giardia (n 15 [3%]), norovirus GI (n 15 [3%]), E. coli
O157 (n 11 [2%]), Shiga toxin-producing E. coli (STEC) (n 8
[2%]), and E. histolytica (n 4 [1%]).
Validation. To initially validate the xTAG GPP, 40 stool sam-
ples positive for Shigella spp., 40 samples positive for Salmonella
spp., and 30 samples positive for Campylobacter spp. by microbi-
ological culture were retested using the xTAG GPP, as shown in
Table 1. The proportion of positive agreement of xTAG GPP and
microbiological culture was high, ranging from 90 to 100%. Fur-
thermore, using stool samples, a previously detected viral patho-
gen by real-time PCR, the xTAG GPP, had similarly high agree-
ment (90.5 to 93.0%) in 68 samples positive for rotavirus, 58
samples positive norovirus GI/GII, and 17 samples positive for
adenovirus 40/41 infections.
Negative-specimen evaluation. A total of 307 fecal samples
that were negative by microbiological culture and real-time PCR
were tested by xTAG GPP. Salmonella was the most frequently
detected pathogen, present in 45% (138/307) of the initially neg-
ative specimens. Further, rotavirus and Shigella spp. were identi-
TABLE 1 Number of positive Luminex xTAG GPP results on samples
known to be positive by microbiological culture and real-time PCR
Pathogen detected
by method
No. detected by
culture/real-time PCR
No. detected
by GPP
% positive
agreement
Culture
Shigella 40 40 100
Salmonella 40 38 95.0
Campylobacter 30 27 90.0
Real-time PCR
Rotavirus 68 63 92.6
Norovirus GI/GII 58 54 93.1
Adenovirus 20 17 85.0
Shigella 44 44 100
Salmonella 48 45 93.8
Campylobacter 40 36 90.0
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FIG 1 Count of pathogens detected by the Luminex xTAG gastrointestinal pathogen panel in 307 specimens that tested negative by microbiological culture and
real-time PCR.
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fied in 19% (57/307) and 16% (48/307) of the negative specimens,
respectively. Additionally, several significant enteric pathogens
that are not well studied (or even previously described in Viet-
nam) due to a lack of diagnostic capacity were also identified,
including Cryptosporidium (15% [45/307 specimens]), C. difficile
(12% [36/307 specimens]), and pathogenic E. coli (14% [42/307
specimens]), as shown in Fig. 1.
Performance evaluation on clinical specimens.Table 2 shows
the performance of xTAG GPP in comparison to both a positive
microbiological culture and a real-time PCR positive gold stan-
dard for seven enteric pathogens, including Shigella spp., Campy-
lobacter spp., and Salmonella spp., and also rotavirus, norovirus
GI/GII, and adenovirus. The xTAGGPPhadhigh sensitivity for all
pathogens, ranging from 88.2% to 100% using both culture and
real-time PCR as gold standards. The specificity of xTAGGPPwas
also moderately high for most of the detected bacterial and viral
pathogens, ranging from 88.4% to 99.3%, with the notable excep-
tion of Salmonella species. A total of 128 and 172 stool specimens
were negative for Salmonella spp. by real-time PCR and culture,
respectively, butwere positive by the xTAGGPP assay, resulting in
specificities of the xTAG GPP assay of 60.8% and 66.8% for Sal-
monella in comparison to real-time PCR and culture, respectively.
However, when we attempted to redefine the cutoff values to im-
prove the specificity, we found no adjusted cutoff rules that sig-
nificantly improved the sum of the sensitivity and specificity for
probes 1 and 2 combined compared to that of the originally de-
fined cutoffs, according to the manufacturer’s instructions.
Coinfection. Of all evaluated stool samples with a detected
pathogen, 58% (233/404 samples) had more than one enteric
pathogen identified by the xTAGGPP assay. Themajority of coin-
fections had two pathogens detected, although the number of de-
tected pathogens was as high as seven in one sample. As shown in
Fig. 2, Cryptosporidium spp. and ETEC were the most common
pathogens detected in stool samples, with other pathogens, in-
cluding E. histolytica, Salmonella spp., rotavirus, and norovirus
with Cryptosporidium spp. and STEC, C. difficile, and adenovirus
with ETEC. Additionally, norovirus and rotavirus were com-
monly identified in the same sample. Notably, patients withCam-
pylobacter infections tended to have negative correlations with
most other pathogens, suggesting a higher prevalence of monoin-
fection.
DISCUSSION
Diarrheal disease is the second most common cause of death in
children 5 years of age globally (3). The need for rapid and
reliable diagnostics is important for treatment decisions and is
even more pressing given the alarming trends of antimicrobial
resistance in many of the most common bacterial enteric patho-
gens (24), whichmay in part be due to the unregulated and exces-
sive use of antimicrobials worldwide. In this study, we demon-
strate that themultiplexmolecular Luminex xTAGGPP detection
system is both highly sensitive and specific compared to both mi-
crobiological culture and real-time PCR for the majority of the
surveyed pathogens. Additionally, the xTAG GPP system allowed
for identification of a number of important pathogens, including
ETEC and Cryptosporidium spp., which are not detected through
routine procedures in hospitals inVietnamor across other parts of
Southeast Asia.
The sensitivity and specificity of the xTAGGPPwere88% for
all compared pathogens (three bacteria and four viruses) using
both culture and real-time PCR; however, a notable exceptionwas
Salmonella. Our sensitivity and specificity findings are similar to, if
TABLE 2 Sensitivity and specificity of Luminex xTAG GPP in comparison to real-time PCR and microbiological culturea
Organism
detected
xTAG GPP compared to real-time PCR xTAG GPP compared to culture
GPP
result
No. with
real-time
PCR result
of:
Sensitivity (%
[95% CI])
Specificity (%
[95% CI])
GPP
result
No. with
culture
result of:
Sensitivity (%
[95% CI])
Specificity (%
[95% CI])Pos Neg Pos Neg
Shigella Pos 86 6 95.6 (89.0–98.8) 98.5 (96.7–99.4) Pos 40 51 100 (91.2–100) 88.4 (85.0–91.2)
Neg 4 383 Neg 0 388
Salmonella Pos 84 128 90.3 (82.4–95.5) 66.8 (61.9–71.5) Pos 38 172 95.0 (83.1–99.4) 60.8 (56.1–65.4)
Neg 9 258 Neg 2 267
Campylobacter Pos 59 3 90.8 (81.0–96.5) 99.3 (97.9–99.8) Pos 27 35 90.0 (73.5–97.9) 92.2 (89.3–94.5)
Neg 6 411 Neg 3 414
Adenovirus Pos 23 5 92.0 (74.0–99.0) 98.9 (97.4–99.6)
Neg 2 449
Norovirus GI Pos 15 5 88.2 (63.6–98.5) 98.9 (97.5–99.6)
Neg 2 457
Norovirus GII Pos 85 4 96.6 (90.4–99.3) 99.0 (97.4–99.7)
Neg 3 387
Rotavirus Pos 117 4 92.9 (86.9–96.7) 98.9 (97.1–99.7)
Neg 9 349
a GPP, gastrointestinal pathogen panel; Pos, positive; Neg, negative; 95% CI, confidence interval.
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somewhat lower than, those of other studies conducted in the
North America, Europe, and China (11–13, 25). The low specific-
ity (60%) of Salmonella detection in our study has not com-
monly been reported in other studies, althoughWessels et al. (26)
found a higher rate of false-positive Salmonella detection in a
small study from the Netherlands. This may be due to a high rate
of asymptomatic carriage with Salmonella in Vietnamese children
(8) or cross-reactivity with an alternative component of the gas-
trointestinal microbiota present in this population. The low spec-
ificity of the xTAG for detecting Salmonella likely led to an artifi-
cially inflated rate of overall coinfection in our samples (58% of
positive samples) compared to that in work conducted elsewhere
(13, 25, 27, 28). However, the rates of pairwise coinfections, such
as C. difficile and Cryptosporidium spp., are similar to those found
in a multicenter Italian study (29). An obvious issue raised by the
high rate of coinfection and the use of the xTAGGPP in general is
pathogenicity. Platts-Mills and colleagues (5) recently found that
Cryptosporidium spp., STEC, and Shigella spp. were more com-
monly associated with severe diarrhea than other pathogens
through a birth cohort that sampled healthy and diarrheal stools.
In order to investigate relative pathogenicity in the future, use of
the xTAG GPP platform in combination with a quantitative tech-
nique (30) may provide more insight into the relationship be-
tween the presence of a pathogen and clinical disease.
Through the use of the xTAG GPP platform, we were able to
identify a far wider range of pathogens than those normally
screened in hospitals and in research studies in Vietnam. Crypto-
sporidium for example, was the fifth most common pathogen de-
tected in our sample set (17%), although almost nothing is known
about the epidemiology of this parasite in Vietnam. Globally,
Cryptosporidium is known to be common in young children with
moderate-to-severe diarrhea and can commonly be identified at a
very high rate (15 to 25%) in children with persistent diarrhea (4,
31). Because the intestinal damage due to infection with Crypto-
sporidium can result severe long-term sequelae (32), specific stud-
ies on this parasite and its epidemiology are warranted. Addition-
ally, 9% of the patients in our cross-sectional sample had C.
difficile detected in their stool.C. difficile is known to bemuch less
common in children than adults, and asymptomatic infection
with toxigenic strains is common (33–35) and may represent a
reservoir for infection (36), although additional investigation into
the epidemiology and clinical significance of C. difficile infection
in children in this setting is warranted. The xTAG GPP assay al-
lows for the detection of such important pathogens and may aid
not only in treatment decisions but also in the generation of hy-
potheses for further epidemiological and etiological studies.
While the benefits of the xTAG GPP system are numerous, a
significant drawback for use in a country, such as Vietnam, is the
cost. The price of a single xTAGGPP reaction is currently prohib-
itive for Vietnam, although recent work from the United King-
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dom has demonstrated that routine use of the multiplex diagnos-
tic led to massive savings at the hospital level due to rapid
identification of noninfectious diarrheal disease and subsequent
reduction of the need for single-patient rooms that far exceeded
the cost of implementing the xTAG GPP itself (37). Whether or
not such economic analyses are applicable to Vietnam is question-
able, and future such analyses tailored to industrializing regions
are recommended. An additional drawback is the lack of an or-
ganism for antimicrobial susceptibility testing. Given the rampant
antimicrobial resistance found in pathogens, such as Shigella spp.,
in Vietnam (8), this is a significant limitation.
Our study has several limitations. First, the microbiological
culture was performed at different laboratories across Vietnam
and may have introduced variability into our results. Second, we
were not able to identify some pathogens, such as V. cholerae or
Yersinia, so we were unable to evaluate the performance of the
xTAG GPP against these pathogens, which may be more relevant
in other settings across the region. Notwithstanding these limita-
tions, our results shed valuable insight into the accuracy of the
xTAG GPP system and its utility in an industrializing setting.
In conclusion, the Luminex xTAG GPP diagnostic platform is
highly sensitive and specific for common bacterial and viral en-
teric pathogens in Vietnam, with the notable exception of Salmo-
nella species. Furthermore, the xTAG GPP platform allowed for
detection of a number of important pathogens that are not rou-
tinely identified through current hospital laboratory procedures
in Vietnam. While there are a number of benefits to the xTAG
GPP platform, cost and lack of an organism for antimicrobial
susceptibility testing may represent barriers to widespread use in
low-income regions. However, the use of such a diagnostic in
locations, like HCMC, Vietnam, would dramatically improve the
ability of clinicians to appropriately treat gastrointestinal infec-
tions in a timelymanner, provide evidence for amore prudent use
of antimicrobials, and allow for an unprecedented level of epide-
miological granularity to aid in prevention and control efforts for
diarrheal disease.
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